Total Payments
$31,640
2024 Payments
$802.30
Companies
22
Transactions
219
Medicare Patients
5,743
Medicare Billing
$581,158
Payment Breakdown by Category
Other$19,000 (60.1%)
Consulting$6,518 (20.6%)
Food & Beverage$4,588 (14.5%)
Travel$1,498 (4.7%)
Education$35.93 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,000 | 7 | 60.1% |
| Consulting Fee | $6,518 | 2 | 20.6% |
| Food and Beverage | $4,588 | 202 | 14.5% |
| Travel and Lodging | $1,498 | 7 | 4.7% |
| Education | $35.93 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $21,612 | 73 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $8,095 | 63 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $423.57 | 25 | $0 (2023) |
| Daiichi Sankyo Inc. | $381.25 | 17 | $0 (2024) |
| Apollo Endosurgery US Inc | $182.86 | 3 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $179.63 | 3 | $0 (2019) |
| NESTLE HEALTHCARE NUTRITION INC. | $139.34 | 7 | $0 (2023) |
| PORTOLA PHARMACEUTICALS, INC. | $90.15 | 1 | $0 (2018) |
| PFIZER INC. | $77.10 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $67.15 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $802.30 | 36 | Daiichi Sankyo Inc. ($213.07) |
| 2023 | $302.91 | 12 | ABBVIE INC. ($138.28) |
| 2022 | $368.28 | 20 | Daiichi Sankyo Inc. ($90.39) |
| 2021 | $347.03 | 24 | Intercept Pharmaceuticals, Inc. ($127.31) |
| 2020 | $276.94 | 16 | AbbVie Inc. ($105.93) |
| 2019 | $13,124 | 33 | Takeda Pharmaceuticals U.S.A., Inc. ($7,680) |
| 2018 | $5,830 | 48 | AbbVie, Inc. ($5,387) |
| 2017 | $10,589 | 30 | AbbVie, Inc. ($10,357) |
All Payment Transactions
219 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/25/2024 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $17.74 | General |
| Category: Elastography | ||||||
| 11/07/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Immunology | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/17/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/07/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/07/2024 | Boston Scientific Corporation | Radial Jaw 4 (Device) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Radial Jaw 4_ENDO | ||||||
| 09/23/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: LIVER DISEASE | ||||||
| 09/17/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/27/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $5.94 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $30.97 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/06/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $31.23 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.69 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/15/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.93 | General |
| Category: IMMUNOLOGY | ||||||
| 07/09/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/18/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,242 | 1,505 | $394,285 | $122,634 |
| 2022 | 18 | 1,369 | 1,652 | $425,885 | $132,467 |
| 2021 | 20 | 1,589 | 1,972 | $476,541 | $172,091 |
| 2020 | 21 | 1,543 | 1,867 | $580,749 | $153,966 |
Total Patients
5,743
Total Services
6,996
Medicare Billing
$581,158
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 217 | 289 | $63,979 | $25,729 | 40.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 275 | 329 | $46,060 | $19,775 | 42.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 83 | 83 | $45,650 | $11,296 | 24.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 178 | 184 | $64,867 | $11,116 | 17.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 89 | 89 | $27,412 | $9,910 | 36.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 77 | 80 | $18,960 | $7,961 | 42.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 36 | 36 | $23,328 | $6,506 | 27.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 63 | 161 | $10,948 | $6,107 | 55.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 48 | 73 | $9,198 | $4,421 | 48.1% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 47 | 49 | $18,066 | $4,412 | 24.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 30 | 30 | $15,885 | $3,840 | 24.2% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 18 | 21 | $17,535 | $3,081 | 17.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 16 | 16 | $11,344 | $2,784 | 24.5% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2023 | 22 | 22 | $11,462 | $2,624 | 22.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $6,231 | $2,150 | 34.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $3,360 | $923.20 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 222 | 309 | $68,406 | $27,182 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 339 | 396 | $55,440 | $24,127 | 43.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 197 | 211 | $66,676 | $12,051 | 18.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 93 | 93 | $28,644 | $10,095 | 35.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 91 | 95 | $22,515 | $9,720 | 43.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 43 | 45 | $26,235 | $8,391 | 32.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 62 | 62 | $34,100 | $7,393 | 21.7% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2022 | 18 | 20 | $21,240 | $6,808 | 32.1% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 58 | 60 | $21,060 | $5,508 | 26.2% |
About Dr. Elias Ghandour, M.D
Dr. Elias Ghandour, M.D is a Specialist healthcare provider based in Lubbock, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699719138.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elias Ghandour, M.D has received a total of $31,640 in payments from pharmaceutical and medical device companies, with $802.30 received in 2024. These payments were reported across 219 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($19,000).
As a Medicare-enrolled provider, Ghandour has provided services to 5,743 Medicare beneficiaries, totaling 6,996 services with total Medicare billing of $581,158. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Gastroenterology
- Location Lubbock, TX
- Active Since 06/15/2006
- Last Updated 04/08/2024
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699719138
Products in Payments
- Mavyret (Drug) $12,830
- Entyvio (Biological) $7,665
- Viekira (Drug) $5,225
- OCALIVA (Drug) $423.57
- INJECTAFER (Drug) $381.25
- Dexilant (Drug) $205.94
- ZENPEP (Drug) $186.67
- OVERSTITCH (Device) $182.86
- SKYRIZI (Biological) $173.29
- Creon (Drug) $164.25
- LINZESS (Drug) $111.71
- XIFAXAN (Drug) $106.76
- CREON (Drug) $105.72
- VIBERZI (Drug) $99.51
- MAVYRET (Drug) $92.85
- ENTYVIO (Biological) $91.17
- BEVYXXA (Drug) $90.15
- RINVOQ (Biological) $83.89
- TRULANCE (Drug) $72.87
- DIFICID (Drug) $54.75
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Lubbock
Dr. Mark Scioli, M.d, M.D
Specialist — Payments: $93,902
Specialist $93,902
Dr. Hoa Nguyen, Md, MD
Specialist — Payments: $17,456
Specialist $17,456
Dr. Robert Carr, Md, MD
Specialist — Payments: $5,637
Specialist $5,637
Mrs. Mary Baiyeri, Md, MD
Specialist — Payments: $3,006
Specialist $3,006
Dr. Kenneth Stephenson, Md, MD
Specialist — Payments: $2,661
Specialist $2,661
Christina Belle-Henry, M.d, M.D
Specialist — Payments: $2,243
Specialist $2,243